5-HYDROXYTRYPTAMINE AND TRYPTAMINE PATHWAYS IN SCLERODERMA

被引：52

作者：

STACHOW, A ^{[1
]}

JABLONSKA, S ^{[1
]}

SKIENDZIELEWSKA, A ^{[1
]}

机构：

[1] WARSAW MED SCH,DEPT DERMATOL,PL-02008 WARSAW,POLAND

来源：

BRITISH JOURNAL OF DERMATOLOGY | 1977年 / 97卷 / 02期

关键词：

D O I：

10.1111/j.1365-2133.1977.tb15060.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：147 / 154

页数：8

共 24 条

[1] GASGROINTESTINAL INVOLVEMENT IN SYSTEMIC SCLERODERMA [J].

BENDIXEN, G ;

JARNUM, S ;

OTTESEN, O ;

SCHMIDT, H ;

THOMSEN, K .

DERMATOLOGICA, 1968, 137 (01) :26-+

[2] TRYPTOPHAN-]NIACIN PATHWAY IN SCLERODERMA AND IN DERMATOMYOSITIS [J].

BINAZZI, M ;

CALANDRA, P .

ARCHIV FUR DERMATOLOGISCHE FORSCHUNG, 1973, 246 (02) :142-145

[3]

Chrusciel M, 1965, Przegl Lek, V21, P489

[4]

DEFECINSKATRZEC.E, 1971, 19TH P POL C DERM, P142

[5]

FABRIS F, 1968, GIORN GERONTOL, V16, P801

[6]

FISCHL J, 1964, CLIN CHEM, V10, P281

[7] SCLERODERMA-LIKE LESIONS AND CARCINOID-SYNDROME [J].

FRIES, JF ;

LINDGREN, JA ;

BULL, JM .

ARCHIVES OF INTERNAL MEDICINE, 1973, 131 (04) :550-553

[8] URINARY EXCRETION OF THE SEROTONIN METABOLITE, 5-HYDROXYINDOLEACETIC ACID, IN VARIOUS CLINICAL CONDITIONS [J].

HAVERBACK, BJ ;

SJOERDSMA, A ;

TERRY, LL .

NEW ENGLAND JOURNAL OF MEDICINE, 1956, 255 (06) :270-272

[9]

JABLONSKA S, 1975, SCLERODERMA PSEUDOSC, P254

[10]

JABLONSKA S, 1963, ACTA NEUROVEG WIEN, V24, P50

← 1 2 3 →